|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 3.450 USD | -1.43% |
|
-27.52% | -17.07% |
| 06-29 | Galectin Therapeutics Inc.(NasdaqCM:GALT) added to Russell Small Cap Comp Growth Benchmark | CI |
| 06-29 | Galectin Therapeutics Inc.(NasdaqCM:GALT) added to Russell 2500 Growth Benchmark | CI |
Evolution of the Average Target: Galectin Therapeutics Inc.
Evolution of the Target Price: Galectin Therapeutics Inc.
Changes in Analyst Recommendations: Galectin Therapeutics Inc.
d.4AAZO41211_jU0IP87TfbZ-QGw54zj3LEis7HyWfwGU.uWMrDs44lgmqKyFLnMbvCqvgbn8zuGT_SFtPSxHF9RLXcH10xyWSbYIACw~586d54e6f253b1d5e8d0e519d955672e
| Consensus | Analysts' recommendations evolution (4 months) | Financial estimates divergence | Analysts' Target price divergence | Objective/dr gap | ||
|---|---|---|---|---|---|---|
| - | - | +214.29% | ||||
| +24.99% | ||||||
| +11.38% | ||||||
| +29.66% | ||||||
| +16.86% | ||||||
| +50.89% | ||||||
| +20.22% | ||||||
| -10.56% | ||||||
| +1.85% | ||||||
| +8.69% | ||||||
| Average | +36.83% | |||||
| Weighted average by Cap. | +20.57% |
Analysts' Consensus
Sell
Buy

Mean consensus
BUY
Number of Analysts
1
Last Close Price
3.480USD
Average target price
11.00USD
Spread / Average Target
+216.09%
High Price Target
11.00USD
Spread / Highest target
+216.09%
Low Price Target
11.00USD
Spread / Lowest Target
+216.09%
Analyst Consensus Detail
Consensus revision (last 18 months)
Analysts covering the company
| HC Wainwright |
Sell
Buy

Mean consensus
BUY
Number of Analysts
1
Last Close Price
3.480USD
Average target price
11.00USD
Spread / Average Target
+216.09%
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- GALT Stock
- Consensus Galectin Therapeutics Inc.
Select your edition
All financial news and data tailored to specific country editions
















